Search research articles
Contact Us
Filters
Showing results (21-30 of 65) with videos related to
Page
of 7
Sort By:
Cancer Drug Resistance (Alhambra, Calif.)
|
May 18, 2022
Natural products as a means of overcoming cisplatin chemoresistance in bladder cancer
Ganeshkumar Rajendran, John A Taylor, Benjamin L Woolbright
Urologic Oncology
|
May 19, 2018
Metabolic changes in bladder cancer
Benjamin L Woolbright, Matthew Ayres, John A Taylor
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
March 25, 2020
Late Protective Effect of Netrin-1 in the Murine Acetaminophen Hepatotoxicity Model
Luqi Duan, Benjamin L Woolbright, Hartmut Jaeschke, et al.
Current Opinion in Urology
|
March 12, 2019
Molecular subtyping of bladder cancer: current trends and future directions in 2019
Woodson W Smelser, Benjamin L Woolbright, John A Taylor
Prostaglandins & Other Lipid Mediators
|
January 14, 2020
Prostaglandin E2 as a therapeutic target in bladder cancer: From basic science to clinical trials
Benjamin L Woolbright, Carol C Pilbeam, John A Taylor
Basic & Clinical Pharmacology & Toxicology
|
July 16, 2015
Bile Acid-Induced Toxicity in HepaRG Cells Recapitulates the Response in Primary Human Hepatocytes
Benjamin L Woolbright, Mitchell R McGill, Huimin Yan, et al.
Nature Reviews. Urology
|
May 20, 2024
Preclinical models of bladder cancer: BBN and beyond
David Matye, Juliann Leak, Benjamin L Woolbright, et al.
Molecular Cancer Therapeutics
|
September 13, 2019
Metabolic Flexibility in Cancer: Targeting the Pyruvate Dehydrogenase Kinase:Pyruvate Dehydrogenase Axis
Benjamin L Woolbright, Ganeshkumar Rajendran, Robert A Harris, et al.
Archives of Biochemistry and Biophysics
|
July 3, 2008
Specific regulation of CYP27B1 and VDR in proximal versus distal renal cells
Amandeep Bajwa, Megan N Forster, Aparna Maiti, et al.
Nature Reviews. Urology
|
July 7, 2022
Bladder cancer, inflammageing and microbiomes
Austin Martin, Benjamin L Woolbright, Shahid Umar, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 65) with videos related to
Sort By:
Page
of 7
Cancer Drug Resistance (Alhambra, Calif.)
|
May 18, 2022
Natural products as a means of overcoming cisplatin chemoresistance in bladder cancer
Ganeshkumar Rajendran, John A Taylor, Benjamin L Woolbright
Urologic Oncology
|
May 19, 2018
Metabolic changes in bladder cancer
Benjamin L Woolbright, Matthew Ayres, John A Taylor
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
March 25, 2020
Late Protective Effect of Netrin-1 in the Murine Acetaminophen Hepatotoxicity Model
Luqi Duan, Benjamin L Woolbright, Hartmut Jaeschke, et al.
Current Opinion in Urology
|
March 12, 2019
Molecular subtyping of bladder cancer: current trends and future directions in 2019
Woodson W Smelser, Benjamin L Woolbright, John A Taylor
Prostaglandins & Other Lipid Mediators
|
January 14, 2020
Prostaglandin E2 as a therapeutic target in bladder cancer: From basic science to clinical trials
Benjamin L Woolbright, Carol C Pilbeam, John A Taylor
Basic & Clinical Pharmacology & Toxicology
|
July 16, 2015
Bile Acid-Induced Toxicity in HepaRG Cells Recapitulates the Response in Primary Human Hepatocytes
Benjamin L Woolbright, Mitchell R McGill, Huimin Yan, et al.
Nature Reviews. Urology
|
May 20, 2024
Preclinical models of bladder cancer: BBN and beyond
David Matye, Juliann Leak, Benjamin L Woolbright, et al.
Molecular Cancer Therapeutics
|
September 13, 2019
Metabolic Flexibility in Cancer: Targeting the Pyruvate Dehydrogenase Kinase:Pyruvate Dehydrogenase Axis
Benjamin L Woolbright, Ganeshkumar Rajendran, Robert A Harris, et al.
Archives of Biochemistry and Biophysics
|
July 3, 2008
Specific regulation of CYP27B1 and VDR in proximal versus distal renal cells
Amandeep Bajwa, Megan N Forster, Aparna Maiti, et al.
Nature Reviews. Urology
|
July 7, 2022
Bladder cancer, inflammageing and microbiomes
Austin Martin, Benjamin L Woolbright, Shahid Umar, et al.
Page
of 7